北美生物信息学人工智能市场 – 行业趋势和 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

北美生物信息学人工智能市场 – 行业趋势和 2029 年预测

  • Healthcare IT
  • Published Report
  • Jun 2023
  • North America
  • 350 页面
  • 桌子數: 34
  • 图号: 43

North America Ai In Bioinformatics Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2022 –2029
Diagram Market Size (Base Year)
USD 1,000.00 Million
Diagram Market Size (Forecast Year)
USD 19,677.40 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

北美人工智能生物信息学市场,按产品(服务、软件和其他)、类型(机器学习、深度学习和其他)、产品和服务(生物信息学服务、生物信息学平台和知识管理工具)、应用(基因组学、化学信息学和药物设计、蛋白质组学、DNA 测序、系统生物学、转录组学、文本挖掘、微阵列、代谢组学和其他)、部门(医学生物技术、动物生物技术、植物生物技术、环境生物技术、法医生物技术等)划分 - 行业趋势和预测到 2029 年。

北美生物信息学市场中的人工智能

北美生物信息学人工智能市场分析及规模

降低基因测序成本增强了市场需求。为获得更好的医疗服务而增加的医疗支出也促进了市场的增长。在这一关键时期,主要市场参与者专注于各种服务的推出和批准。此外,对生物信息学的需求不断增长以及公共和私营部门对生物信息学的资助不断增加也促进了市场需求的增长。

北美生物信息学市场中的人工智能

北美生物信息学市场中的人工智能

由于市场参与者的增加和先进服务的可用性,北美生物信息学人工智能市场在预测年内将增长。与此同时,制造商正致力于研发活动,以在市场上推出新服务。生物信息学技术的不断进步进一步推动了市场增长。然而,生物信息学仪器的高成本和网络安全问题可能会阻碍预测期内北美生物信息学人工智能市场的增长。

技术进步和现代化的不断推进,以及市场参与者的战略举措,为市场带来了机遇。然而,缺乏熟练的专业人员来执行基于人工智能的生物信息学技术以及在临床实验室实施生物信息学技术的挑战是市场增长面临的关键挑战。

Data Bridge Market Research 分析,北美生物信息学人工智能市场预计到 2030 年将达到 196.774 亿美元,预测期内复合年增长率为 45.2%。北美生物信息学人工智能市场报告还全面涵盖了定价分析、专利分析和技术进步。     

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020 (可定制为 2019-2014)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

 产品(服务、软件和其他)、类型(机器学习、深度学习和其他)、产品和服务(生物信息学服务、生物信息学平台和知识管理工具)、应用(基因组学、化学信息学和药物设计、蛋白质组学、DNA 测序、系统生物学、转录组学、文本挖掘、微阵列、代谢组学和其他)、行业(医学生物技术、动物生物技术、植物生物技术、环境生物技术、法医生物技术和其他)

覆盖国家

美国、加拿大和墨西哥

涵盖的市场参与者

JADBio & Gnosis Data Analysis、SOPHiA GENETICS、Biomax Informatics AG、DNASTAR、Ardigen、QIAGEN、Source BioScience.、NeoGenomics Laboratories、Eurofins Scientific、Illumina, Inc.、Thermo Fisher Scientific Inc.、CelbridgeScience.、Dassault Systemes、Fios Genomics、Insilico Medicine、Strand Life Sciences、Paige AI, Inc.、SomaLogic Operating Co., Inc. 和 iNDX. Ai. Elucidata。

市场定义

北美生物信息学人工智能市场是指北美地区将人工智能 (AI) 技术应用于生物信息学领域的领域。生物信息学涉及使用计算方法和技术来分析和解释生物数据,例如基因组序列、蛋白质结构和大规模生物实验。

生物信息学结合了计算机编程、大数据和分子生物学,使科学家能够理解和识别生物数据中的模式。它在研究基因组和 DNA 测序方面特别有用,因为它允许科学家组织大量数据。

生物学有许多分支学科可供研究,包括遗传学、毒理学、真菌学和放射生物学。在众多学科中,生物信息学是最有趣的领域之一,它能够识别、评估、存储和检索生物信息。作为一门跨学科的研究领域,它结合了计算机科学、统计学和生物学的各种应用,开发用于理解生物数据的软件应用程序,例如 DNA 测序、蛋白质分析、进化遗传学等。

北美生物信息学人工智能市场动态

本节旨在了解市场驱动因素、优势、机遇、限制和挑战。下面将详细讨论所有这些内容:

驱动程序

  • 降低基因测序成本

降低基因组学和生物标志物预测成本的强烈需求促成了高通量基因组测序的诞生,这通常被称为下一代测序 (NGS)。单个生物信息学循环中会同时生成数千或数百万个序列。工业 NGS 技术的大幅升级导致每碱基 DNA 测序成本大幅降低。因此,主要测序技术最近已成为关键研究课题,而样本设计优化则发挥了次要作用。

新一代测序技术可以并行处理数亿个 DNA 模板,大大提高了测序效率,降低了测序成本。此外,自人类基因组计划完成以来,生物信息学的成本大幅下降,超过了摩尔定律。Illumina 通过不断创新,帮助降低了生物信息学仪器的成本,使人类基因组测序成本降至 1000 美元。

  • 生物信息学需求不断增长

随着以基因组学为重点的药理学在治疗各种慢性疾病(尤其是癌症)方面发挥着越来越重要的作用,新一代测序 (NGS) 正在发展成为一种强大的工具,可以更深入、更准确地了解单个肿瘤和特定受体的分子基础。信息学在涉及学习编程的生物学家、计算机程序员、数学家或学习生物学基础知识的数据库管理员的生物学研究中至关重要。

与传统方法相比,NGS 在准确性、灵敏度和速度方面具有优势,有可能对肿瘤学领域产生重大影响。由于 NGS 可以在一次检测中评估多个基因,因此无需进行多次测试来确定致病突变。生物信息学中的人工智能对于现代生物学和医学中的数据管理非常重要。

生物信息学的应用日益广泛,这得益于生物数据的激增、数据整合和分析的需求、其在药物发现和个性化医疗中的应用、其对理解复杂生物系统的贡献以及其在进化生物学和系统发育中的作用。生物信息学在推进生物研究、改善医疗保健和应对生命科学中的各种挑战方面发挥着重要作用。

北美生物信息学市场中的人工智能

机会

  • 医疗支出增加

世界许多国家都观察到政府在医疗支出方面的增长。随着各国人民可支配收入的增加,全球医疗支出也在增加。此外,为了满足人口需求,政府机构和医疗组织正在采取主动行动,加快医疗支出。随着人口老龄化,对医疗服务的需求增加,包括慢性病管理、长期护理和临终关怀。老年人口往往需要更多的医疗资源和服务,从而导致更高的医疗支出。在某些情况下,许多政府组织改善了医疗保健的坚实资金,从而促进了医疗保健市场的发展,并为北美生物信息学市场的人工智能创造了重大机遇。

克制/挑战

  • 生物信息学中的网络安全问题

生物信息学数据集包含敏感信息,包括基因组数据、个人健康信息和研究数据。如果未经授权的个人通过网络安全防御漏洞获取这些数据,则可能导致隐私侵犯、身份盗窃或数据滥用。

然而,DNA 技术和生物技术日益计算机化,更广泛地说,引发了新的生物网络安全问题。通常与传统计算机系统相关的漏洞——例如处理不受信任的输入、侧信道泄漏、身份验证不当、伪造数据和网络物理系统中的漏洞——现在也存在于生物技术中。新兴的生物网络安全威胁已经威胁到生物信息学中的 DNA 信息系统。

后新冠疫情对北美生物信息学市场 AI 的影响

由于封锁和 COVID-19,生物信息学行业中的 AI 需求有所下降。政府法律规定,制造设施和服务都关闭了。COVID-19 对各行各业产生了重大影响,因为几乎每个国家都选择关闭除经营必需品部门的设施以外的所有设施。政府采取了一些严格的措施,例如关闭设施和销售非必需品、封锁国际贸易等,以防止 COVID-19 的传播。这促进了北美生物信息学 AI 市场的发展,因为消费者正在购买保险,以避免在有医疗需求时在医院支付巨额资本金。因此,COVID-19 对北美生物信息学 AI 市场产生了积极影响。

最新动态

  • 2022 年 9 月,TechBio 公司 Elucidata 在 A 轮融资中成功筹集 1600 万美元。本轮融资由 Eight Roads Ventures 领投。该公司计划利用新获得的资金来增强转化药物研究和相关市场的产品能力。此外,这些资金还将支持扩大上市计划,并使公司能够在全球范围内拓展业务。
  • 2022 年 1 月,中国领先的创新驱动型国际医疗集团上海复星医药(集团)股份有限公司与端到端人工智能 (AI) 驱动的药物发现和开发公司 Insilico Medicine 达成合作协议,通过 AI 技术推动全球针对多个靶点的药物发现和开发。此举帮助该公司扩大了市场产品组合并提升了全球影响力

北美生物信息学人工智能市场范围

北美生物信息学人工智能市场根据产品、类型、产品和服务、应用和行业进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

奉献

  • 服务
  • 软件
  • 其他的

根据产品供应,北美生物信息学人工智能市场分为服务、软件和其他。   

类型

  • 机器学习
  •  深度学习
  •  其他的

根据类型,北美生物信息学人工智能市场分为机器学习、深度学习和其他。

产品和服务

  • 生物信息学服务
  • 生物信息学平台
  • 知识管理工具

根据产品和服务,北美生物信息学人工智能市场分为生物信息学服务、生物信息学平台和知识管理工具。

应用

  • 基因组学
  • 化学信息学与药物设计
  • 蛋白质组学
  • DNA 测序
  • 系统生物学
  • 转录组学
  • 文本挖掘
  • 微阵列
  • 代谢组学
  • 其他的

根据应用,北美生物信息学人工智能市场细分为基因组学、化学信息学和药物设计、蛋白质组学、DNA测序、系统生物学、转录组学、文本挖掘、微阵列、代谢组学等。

部门

  • 医学生物技术
  • 动物生物技术
  • 植物生物技术
  • 环境生物技术
  • 法医生物技术
  • 其他的

根据行业划分,北美生物信息学人工智能市场分为医学生物技术、动物生物技术、植物生物技术、环境生物技术、法医生物技术等。

生物信息学市场中的人工智能

北美生物信息学人工智能市场区域分析/洞察

对北美生物信息学人工智能市场进行了分析,并按国家、产品、类型、产品和服务、应用和上述行业提供了市场规模洞察和趋势。

北美生物信息学人工智能市场报告涵盖的国家包括美国、加拿大和墨西哥。由于对生物信息学设备中人工智能的需求很高,美国在北美地区占据主导地位。此外,美国拥有强大的研发生态系统,在科学研究方面投入了大量资金。该国领先的大学和研究机构为生物信息学领域做出了重大贡献,包括人工智能技术的应用。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测各个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了北美品牌的存在和可用性以及由于来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税的影响和贸易路线。   

竞争格局和北美生物信息学人工智能市场份额分析

北美生物信息学 AI 市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、北美业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对北美生物信息学 AI 市场的关注有关。

北美生物信息学人工智能市场的一些主要参与者包括 JADBio & Gnosis Data Analysis、SOPHiA GENETICS、Biomax Informatics AG、DNASTAR、Ardigen、QIAGEN、Source BioScience.、NeoGenomics Laboratories、Eurofins Scientific、Illumina, Inc.、Thermo Fisher Scientific Inc.、CelbridgeScience.、Dassault Systemes Fios Genomics、Insilico Medicine、Strand Life Sciences、Paige AI, Inc.、SomaLogic Operating Co., Inc.、iNDX. Ai. 和 Elucidata 等。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA AI IN BIOINFORMATICS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 OFFERING LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET SECTOR COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER'S FIVE FORCES

5 NORTH AMERICA AI IN BIOINFORMATICS MARKET :MARKET OVERVIEW

5.1 DRIVERS

5.1.1 REDUCTION IN THE GENETIC SEQUENCING COST

5.1.2 GROWING DEMAND FOR BIOINFORMATICS

5.1.3 INCREASING PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS

5.2 RESTRAINTS

5.2.1 HIGH COST OF INSTRUMENTATION

5.2.2 CYBERSECURITY CONCERNS IN BIOINFORMATICS

5.3 OPPORTUNITIES

5.3.1 RISE IN HEALTHCARE EXPENDITURE

5.3.2 STRATEGIC INITIATIVES BY KEY PLAYERS

5.3.3 ADVANCEMENT IN BIOINFORMATICS TECHNOLOGY

5.4 CHALLENGES

5.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM AI-BASED BIOINFORMATICS TECHNOLOGY

5.4.2 CHALLENGES OF IMPLEMENTING BIOINFORMATIC TECHNOLOGY IN THE CLINICAL LAB

6 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY OFFERING

6.1 OVERVIEW

6.2 SERVICES

6.3 SOFTWARE

6.4 OTHERS

7 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY TYPE

7.1 OVERVIEW

7.2 MACHINE LEARNING

7.3 DEEP LEARNING

7.4 OTHERS

8 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES

8.1 OVERVIEW

8.2 BIOINFORMATICS SERVICES

8.2.1 DATA ANALYSIS

8.2.2 SEQUENCING SERVICES

8.2.3 DATABASE MANAGEMENT

8.2.4 OTHERS

8.3 BIOINFORMATICS PLATFORMS

8.3.1 SEQUENCE ANALYSIS PLATFORMS

8.3.2 SEQUENCE ALIGNMENT PLATFORMS

8.3.3 STRUCTURAL ANALYSIS PLATFORMS

8.3.4 SEQUENCE MANIPULATION PLATFORMS

8.3.5 OTHERS

8.4 KNOWLEDGE MANAGEMENT TOOLS

8.4.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS

8.4.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS

9 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 GENOMICS

9.3 CHEMOINFORMATICS & DRUG DESIGN

9.4 PROTEOMICS

9.5 DNA SEQUENCING

9.6 SYSTEM BIOLOGY

9.7 TRANSCRIPTOMICS

9.8 TEXT MINING

9.9 MICROARRAYS

9.1 METABOLOMICS

9.11 OTHERS

10 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY SECTOR

10.1 OVERVIEW

10.2 MEDICAL BIOTECHNOLOGY

10.3 ANIMAL BIOTECHNOLOGY

10.4 PLANT BIOTECHNOLOGY

10.5 ENVIRONMENTAL BIOTECHNOLOGY

10.6 FORENSIC BIOTECHNOLOGY

10.7 OTHERS

11 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY COUNTRY

11.1 U.S.

11.2 CANADA

11.3 MEXICO

12 NORTH AMERICA AI IN BIOINFORMATICS MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

13 SWOT ANALYSIS

14 COMPANY PROFILE

14.1 ILLUMINA, INC.

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 PRODUCT PORTFOLIO

14.1.4 RECENT DEVELOPMENTS

14.2 DASSAULT SYSTEMES

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 PRODUCT PORTFOLIO

14.2.4 RECENT DEVELOPMENT

14.3 EUROFINS SCIENTIFIC

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 PRODUCT PORTFOLIO

14.3.4 RECENT DEVELOPMENT

14.4 THERMO FISHER SCIENTIFIC INC.

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 PRODUCT PORTFOLIO

14.4.4 RECENT DEVELOPMENT

14.5 QIAGEN

14.5.1 COMPANY SNAPSHOT

14.5.2 PRODUCT PORTFOLIO

14.5.3 RECENT DEVELOPMENT

14.6 ARDIGEN

14.6.1 COMPANY SNAPSHOT

14.6.2 PRODUCT PORTFOLIO

14.6.3 RECENT DEVELOPMENT

14.7 BIOMAX INFORMATICS AG

14.7.1 COMPANY SNAPSHOT

14.7.2 PRODUCT PORTFOLIO

14.7.3 RECENT DEVELOPMENT

14.8 CELBRIDGESCIENCE.

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENTS

14.9 DNASTAR

14.9.1 COMPANY SNAPSHOT

14.9.2 PRODUCT PORTFOLIO

14.9.3 RECENT DEVELOPMENT

14.1 ELUCIDATA

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENT

14.11 INDX. AI.

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENTS

14.12 INSILICO MEDICINE

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT DEVELOPMENTS

14.13 JADBIO & GNOSIS DATA ANALYSIS

14.13.1 COMPANY SNAPSHOT

14.13.2 PRODUCT PORTFOLIO

14.13.3 RECENT DEVELOPMENTS

14.14 NEOGENOMICS LABORATORIES

14.14.1 COMPANY SNAPSHOT

14.14.2 REVENUE ANALYSIS

14.14.3 PRODUCT PORTFOLIO

14.14.4 RECENT DEVELOPMENT

14.15 PAIGE AI, INC.

14.15.1 COMPANY SNAPSHOT

14.15.2 PRODUCT PORTFOLIO

14.15.3 RECENT DEVELOPMENT

14.16 SOMALOGIC OPERATING CO., INC.

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT DEVELOPMENT

14.17 SOPHIA GENETICS

14.17.1 COMPANY SNAPSHOT

14.17.2 PRODUCT PORTFOLIO

14.17.3 RECENT DEVELOPMENT

14.18 SOURCE BIOSCIENCE.

14.18.1 COMPANY SNAPSHOT

14.18.2 PRODUCT PORTFOLIO

14.18.3 RECENT DEVELOPMENT

15 QUESTIONNAIRE

16 RELATED REPORTS

表格列表

TABLE 1 BIOINFORMATICS COST PER SAMPLE

TABLE 2 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

TABLE 3 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 4 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 5 NORTH AMERICA BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 6 NORTH AMERICA BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 7 NORTH AMERICA KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 8 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 9 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 10 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 11 U.S. AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

TABLE 12 U.S. AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 13 U.S. AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 14 U.S. BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 15 U.S. BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 16 U.S. KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 17 U.S. AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 18 U.S. AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 19 CANADA AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

TABLE 20 CANADA AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 21 CANADA AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 22 CANADA BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 23 CANADA BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 24 CANADA KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 25 CANADA AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 26 CANADA AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 27 MEXICO AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

TABLE 28 MEXICO AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 29 MEXICO AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 30 MEXICO BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 31 MEXICO BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 32 MEXICO KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 33 MEXICO AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 34 MEXICO AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

图片列表

FIGURE 1 NORTH AMERICA AI IN BIOINFORMATICS MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA AI IN BIOINFORMATICS MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA AI IN BIOINFORMATICS MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA AI IN BIOINFORMATICS MARKET: NORTH AMERICA VS COUNTRY MARKET ANALYSIS

FIGURE 5 NORTH AMERICA AI IN BIOINFORMATICS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA AI IN BIOINFORMATICS MARKET: MULTIVARIATE MODELLING

FIGURE 7 NORTH AMERICA AI IN BIOINFORMATICS MARKET: OFFERING LIFELINE CURVE

FIGURE 8 NORTH AMERICA AI IN BIOINFORMATICS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 9 NORTH AMERICA AI IN BIOINFORMATICS MARKET: DBMR MARKET POSITION GRID

FIGURE 10 NORTH AMERICA AI IN BIOINFORMATICS MARKET: MARKET SECTOR COVERAGE GRID

FIGURE 11 NORTH AMERICA AI IN BIOINFORMATICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 12 NORTH AMERICA AI IN BIOINFORMATICS MARKET: SEGMENTATION

FIGURE 13 THE REDUCTION IN THE GENETIC SEQUENCING COST AND GROWING DEMAND FOR BIOINFORMATICS ARE EXPECTED TO DRIVE THE NORTH AMERICA AI IN BIOINFORMATICS MARKET IN THE FORECAST PERIOD

FIGURE 14 THE SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA AI IN BIOINFORMATICS MARKET IN 2022 & 2029

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA AI IN BIOINFORMATICS MARKET

FIGURE 16 COST OF GENETIC SEQUENCING IN USD (YEAR WISE)

FIGURE 17 POSSIBLE IMPACT OF CYBER ATTACKS ON BIOINFORMATICS

FIGURE 18 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY OFFERING, 2021

FIGURE 19 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY OFFERING, 2022-2029 (USD MILLION)

FIGURE 20 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY OFFERING, CAGR (2022-2029)

FIGURE 21 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY OFFERING, LIFELINE CURVE

FIGURE 22 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY TYPE, 2021

FIGURE 23 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY TYPE, 2022-2029 (USD MILLION)

FIGURE 24 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 25 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 26 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, 2021

FIGURE 27 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, 2022-2029 (USD MILLION)

FIGURE 28 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, CAGR (2022-2029)

FIGURE 29 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, LIFELINE CURVE

FIGURE 30 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY APPLICATION, 2021

FIGURE 31 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY APPLICATION, 2022-2029 (USD MILLION)

FIGURE 32 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 33 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 34 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY SECTOR, 2021

FIGURE 35 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY SECTOR, 2022-2029 (USD MILLION)

FIGURE 36 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY SECTOR, CAGR (2022-2029)

FIGURE 37 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY SECTOR, LIFELINE CURVE

FIGURE 38 NORTH AMERICA AI IN BIOINFORMATICS MARKET: SNAPSHOT (2021)

FIGURE 39 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY COUNTRY (2021)

FIGURE 40 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 41 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 42 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY OFFERING (2022-2029)

FIGURE 43 NORTH AMERICA AI IN BIOINFORMATICS MARKET: COMPANY SHARE 2021 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The North America AI in Bioinformatics Market is projected to grow at a CAGR of 45.2% during the forecast period by 2030.
The future market value of the North America AI in Bioinformatics Market is expected to reach USD 19,677.40 million by 2030.
The major players in the North America AI in Bioinformatics Market are JADBio & Gnosis Data Analysis, SOPHiA GENETICS, Biomax Informatics AG, DNASTAR, Ardigen, QIAGEN, Source BioScience., NeoGenomics Laboratories, Eurofins Scientific, Illumina, Inc., Thermo Fisher Scientific Inc., etc.
The countries covered in the North America AI in Bioinformatics Market are U.S., Canada, and Mexico.